XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Awards (Tables)
3 Months Ended
Mar. 31, 2024
Stock-Based Awards  
Summary of assumptions used to determine fair value of stock options granted

    

Three Months Ended

March 31, 

2024

2023

Risk-free interest rate

 

3.81

%

3.46

%

Expected term (in years)

 

6.0

6.3

Expected volatility

 

81.81

%

77.73

%

Expected dividend yield

 

0

%

0

%

Summary of stock option activity

    

    

    

Weighted

    

Weighted

Average

Average

Remaining

Aggregate

Number

Exercise

Contractual

Intrinsic

(In thousands, except share and per share data and years)

of Shares

Price

Term

Value

(in years)

Outstanding as of December 31, 2023

 

6,419,455

$

15.94

 

7.1

$

14

Granted

 

1,842,300

1.20

Forfeited and cancelled

 

(1,294,775)

14.54

Outstanding as of March 31, 2024

 

6,966,980

$

12.32

7.0

$

96

Options vested and expected to vest as of March 31, 2024

 

6,966,980

$

12.32

 

7.0

$

96

Options exercisable as of March 31, 2024

 

3,695,196

$

16.24

 

5.1

$

24

Summary of restricted stock units activity

Weighted

Average

Grant Date

Aggregate

Number

Fair Value

Intrinsic

(In thousands, except share and per share data)

of Shares

Per Share

Value

Outstanding as of December 31, 2023

1,521,940

$

15.72

Granted

2,444,350

1.20

Vested

(399,716)

14.93

$

482

Forfeited and cancelled

(427,035)

13.65

Outstanding as of March 31, 2024

3,139,539

$

4.81

Summary of stock-based compensation expense

Three Months Ended

 

March 31, 

 

(In thousands)

    

    

2024

    

2023

 

Cost of revenue

    

  

$

252

    

$

299

Research and development

(29)

2,602

General and administrative

 

1,866

 

3,905

Total stock-based compensation expense

$

2,089

$

6,806